Sebastiaan J. van Hal, Thomas Le, Frances Jenkins, Ratan L. Kundu, E. Athena Limnios, Lucy McNamara, Shalabh Sharma, Ellen N. Kersh, Monica M. Lahra
{"title":"Neisseria meningitidis Serogroup Y Sequence Type 1466 and Urogenital Infections","authors":"Sebastiaan J. van Hal, Thomas Le, Frances Jenkins, Ratan L. Kundu, E. Athena Limnios, Lucy McNamara, Shalabh Sharma, Ellen N. Kersh, Monica M. Lahra","doi":"10.3201/eid3101.240940","DOIUrl":null,"url":null,"abstract":"<p><em>Neisseria meningitidis</em> is a common commensal bacterium of the nasopharynx that can cause invasive meningococcal disease (IMD). In comparison, <em>N. gonorrhoeae</em> is always a pathogen usually limited to mucosal sites. However, increased evidence for overlapping clinical syndromes is emerging. We compared <em>N.</em> <em>meningitidis</em> samples from a urogenital outbreak in Australia with sequences from the United States and other countries. We conducted phylogenetic analyses to assess relatedness and examine for genomic changes associated with meningococcal adaptation; we collated a total of 255 serogroup Y (MenY), sequence type (ST) 1466 isolate assemblies. Most urogenital isolates originated from Australia; those isolates formed a distinct clade, most closely related genomically to recent US IMD isolates. No specific genomic changes suggested niche adaptation or associated clinical manifestations. The MenY ST1466 <em>N.</em> <em>meningitidis</em> isolates circulating in Australia and the United States are capable of causing both urethritis and invasive meningococcal disease.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":"258 1","pages":""},"PeriodicalIF":7.2000,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3201/eid3101.240940","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Neisseria meningitidis is a common commensal bacterium of the nasopharynx that can cause invasive meningococcal disease (IMD). In comparison, N. gonorrhoeae is always a pathogen usually limited to mucosal sites. However, increased evidence for overlapping clinical syndromes is emerging. We compared N.meningitidis samples from a urogenital outbreak in Australia with sequences from the United States and other countries. We conducted phylogenetic analyses to assess relatedness and examine for genomic changes associated with meningococcal adaptation; we collated a total of 255 serogroup Y (MenY), sequence type (ST) 1466 isolate assemblies. Most urogenital isolates originated from Australia; those isolates formed a distinct clade, most closely related genomically to recent US IMD isolates. No specific genomic changes suggested niche adaptation or associated clinical manifestations. The MenY ST1466 N.meningitidis isolates circulating in Australia and the United States are capable of causing both urethritis and invasive meningococcal disease.
期刊介绍:
Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination.
Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.